GLPwatch
Trials (2101)
Page 16 of 36.
- LIROH - Liraglutide for Obesity in HIV
- GLP1R in Parkinson's Disease
- A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
- A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation III
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
- The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects
- A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c
- A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
- A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
- Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy
- Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide
- Exenatide and Metformin Therapy in Overweight Women With PCOS
- WEgovy Real World Assessment of Weight Loss in Korea
- The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis
- Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
- Feasibility of Semaglutide in Advanced Lung Disease
- Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
- GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis
- A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
- The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
- Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects
- Semaglutide 2.4 mg in Patients With Poor Weight-loss
- A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
- A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
- Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.
- A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
- Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
- Impact of Exenatide on Sleep in Type 2 Diabetes
- CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
- The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers
- Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines
- Role of Exenatide in Type 1 Diabetes
- A Study of Two Different Formulations of LY3502970 in Healthy Participants
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
- Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)
- A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
- Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
- A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
- A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes
- Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH
- Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
- Research of Exenatide for Overweight/Obese PCOS Patients With IGR
- Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
- Incretin and KATP Channels
- A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- Semaglutide's Weight Loss Effects in Obesity
- Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
- Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
- Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
- Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide
- 24-h Energy Expenditure and Anti-obesity Medication
- Liraglutide for Low-responders After Bariatric Surgery
- Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
- Exenatide and Weight Loss for Diabetes Prevention
- [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
- Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity